Principal Investigator
i3S . Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal
Bruno Sarmento is Principal Investigator, Group Leader and member of the Board of Directors at Institute for Research and Innovation in Health (i3S), University of Porto (UP), and Invited Associate Professor at Instituto Universitário de Ciências da Saúde (IUCS), Portugal. His current research is focused on the development of functionalized nanomedicines and their application in the pharmaceutical and biomedical fields. In particular, nanoformulations of biopharmaceutical drugs with interest in diabetes, cancer and infectious diseases. He has also specialized in 3D engineering in vitro models to validate functionalized nanomedicines and to perform in vitro/in vivo correlation. He published 460 papers in international journals, most in top journals. Bruno Sarmento was the first Chair of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society (CRS) and is now Director-at-Large of CRS and member of CRS College of Fellows.
Wednesday, July 26, 2023
11:00 AM – 1:00 PM US PST
